The Atlanta Braves made a swift offseason decision on Friday by declining to offer contracts for the 2027 season to right-handed pitchers Michael Grove and James Karinchak.
The moves, announced as tender deadlines arrived for arbitration-eligible players across Major League Baseball, immediately granted both pitchers free agency and reduced Atlanta’s 40-man roster to 38.
Grove’s brief tenure with the organization ended almost as quickly as it began.
The 29-year-old right-hander joined the Braves via a waiver claim in mid-September after the Tampa Bay Rays designated him for assignment.
He never appeared in a major-league game for Atlanta.
His entire 2026 season consisted of just seven innings in which he allowed four earned runs and recorded six strikeouts, numbers that offered little evidence of a role on the coming roster.
Before arriving in Atlanta, Grove had spent the first three years of his career with the Los Angeles Dodgers. He contributed, at least in a supporting capacity, to the club’s 2024 World Series championship run.
That momentum stalled completely the following year when he missed the entire 2025 campaign with an injury whose effects appeared to linger.
Across parts of four big-league seasons he has now logged 156 1/3 innings with a 5.47 ERA, appearing in 67 games (20 of them starts).
He made his major-league debut in 2022 and carries a career pitching WAR of minus-2.0.
The non-tender leaves Grove free to sign with any club. Given the limited recent workload and the injury history, most evaluators expect him to need minor-league innings before he can re-establish himself at the major-league level.
At the same time, a healthy version of a pitcher who has already thrown more than 150 big-league innings could still attract interest from organizations willing to take a low-cost flier during the winter.
The decision fits a broader pattern of roster pruning as clubs weigh arbitration costs against projected performance.
For Grove, the next several weeks will determine whether another team views his remaining upside as worth the roster spot, or whether the combination of modest results and lost time in 2025 has narrowed his path back to a major-league mound.



